PeptiDream Inc.'s (TSE:4587) 42% Price Boost Is Out Of Tune With Revenues
Apr 30
Japanese (NIKKEI) Biotech Industry Analysis
UpdatedApr 30, 2024
DataAggregated Company Financials
Companies31
- 7D2.4%
- 3M-4.8%
- 1Y-24.1%
- YTD-11.8%
The Biotech industry is up 2.4% in the last week, with PeptiDream up 25%. In the same time, Delta-Fly Pharma was down 8.1%. In contrast, the industry has lost 24% in the last 12 months. As for the next few years, earnings are expected to grow by 31% per annum.
Industry Valuation and Performance
Has the Japanese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 Apr 2024 | JP¥753.2b | JP¥198.9b | -JP¥14,917,877,000.00 | 42.4x | -50.5x | 3.8x |
| Thu, 28 Mar 2024 | JP¥751.2b | JP¥194.2b | -JP¥15,458,035,000.00 | 60x | -48.6x | 3.9x |
| Sat, 24 Feb 2024 | JP¥807.8b | JP¥196.2b | -JP¥18,778,997,000.00 | 65.3x | -43x | 4.1x |
| Mon, 22 Jan 2024 | JP¥781.8b | JP¥222.3b | -JP¥12,604,827,000.00 | 17.1x | -62x | 3.5x |
| Wed, 20 Dec 2023 | JP¥762.5b | JP¥224.2b | -JP¥12,970,409,000.00 | 17x | -58.8x | 3.4x |
| Fri, 17 Nov 2023 | JP¥753.1b | JP¥220.6b | -JP¥9,824,128,000.00 | 16.6x | -76.7x | 3.4x |
| Sun, 15 Oct 2023 | JP¥787.0b | JP¥223.0b | -JP¥14,518,735,000.00 | 22.7x | -54.2x | 3.5x |
| Tue, 12 Sep 2023 | JP¥882.5b | JP¥225.4b | -JP¥19,581,085,000.00 | 45.6x | -45.1x | 3.9x |
| Thu, 10 Aug 2023 | JP¥870.2b | JP¥218.8b | -JP¥24,610,086,000.00 | 51.5x | -35.4x | 4x |
| Sat, 08 Jul 2023 | JP¥939.3b | JP¥223.0b | -JP¥19,224,671,000.00 | 56.9x | -48.9x | 4.2x |
| Mon, 05 Jun 2023 | JP¥955.1b | JP¥218.4b | -JP¥25,405,670,000.00 | 37.6x | -37.6x | 4.4x |
| Wed, 03 May 2023 | JP¥899.1b | JP¥218.2b | -JP¥20,062,522,000.00 | 20.8x | -44.8x | 4.1x |
| Fri, 31 Mar 2023 | JP¥910.8b | JP¥218.3b | -JP¥21,583,164,000.00 | 21.2x | -42.2x | 4.2x |
| Sun, 26 Feb 2023 | JP¥935.9b | JP¥216.2b | -JP¥18,991,580,000.00 | 21x | -49.3x | 4.3x |
| Tue, 24 Jan 2023 | JP¥925.5b | JP¥186.8b | -JP¥24,722,604,000.00 | 39.9x | -37.4x | 5x |
| Thu, 22 Dec 2022 | JP¥846.0b | JP¥186.8b | -JP¥24,723,433,000.00 | 39.5x | -34.2x | 4.5x |
| Sat, 19 Nov 2022 | JP¥908.6b | JP¥182.1b | -JP¥23,616,729,000.00 | 47.6x | -38.5x | 5x |
| Mon, 17 Oct 2022 | JP¥859.1b | JP¥176.5b | -JP¥24,974,270,000.00 | 43.1x | -34.4x | 4.9x |
| Wed, 14 Sep 2022 | JP¥928.8b | JP¥176.4b | -JP¥24,682,270,000.00 | 50.1x | -37.6x | 5.3x |
| Fri, 12 Aug 2022 | JP¥921.2b | JP¥173.7b | -JP¥19,167,889,000.00 | 20.4x | -48.1x | 5.3x |
| Sun, 10 Jul 2022 | JP¥912.6b | JP¥171.3b | -JP¥16,112,943,000.00 | 20.8x | -56.6x | 5.3x |
| Tue, 07 Jun 2022 | JP¥875.3b | JP¥171.2b | -JP¥17,305,721,000.00 | 19.9x | -50.6x | 5.1x |
| Thu, 05 May 2022 | JP¥996.4b | JP¥163.9b | -JP¥13,145,184,000.00 | 14x | -75.8x | 6.1x |
| Sat, 02 Apr 2022 | JP¥1.1t | JP¥164.2b | -JP¥13,045,061,000.00 | 15x | -83.2x | 6.6x |
| Mon, 28 Feb 2022 | JP¥1.0t | JP¥159.9b | -JP¥9,023,798,000.00 | 15.7x | -115.9x | 6.5x |
| Wed, 26 Jan 2022 | JP¥1.0t | JP¥163.5b | -JP¥5,447,358,000.00 | 16x | -189.8x | 6.3x |
| Fri, 24 Dec 2021 | JP¥1.3t | JP¥163.5b | -JP¥5,447,524,000.00 | 18.4x | -233.9x | 7.8x |
| Sun, 21 Nov 2021 | JP¥1.3t | JP¥159.5b | -JP¥8,764,044,000.00 | 20.5x | -148.1x | 8.1x |
| Tue, 19 Oct 2021 | JP¥1.4t | JP¥147.6b | -JP¥12,269,440,000.00 | 23.6x | -113.7x | 9.5x |
| Thu, 16 Sep 2021 | JP¥1.6t | JP¥147.9b | -JP¥14,140,440,000.00 | 26.3x | -116.4x | 11.1x |
| Sat, 14 Aug 2021 | JP¥1.7t | JP¥148.3b | -JP¥14,096,440,000.00 | 23.9x | -117.7x | 11.2x |
| Wed, 09 Jun 2021 | JP¥1.8t | JP¥130.4b | -JP¥17,249,632,000.00 | 37.7x | -106.6x | 14.1x |
Price to Earnings Ratio
-101.8x
Current Industry PE
- Investors are pessimistic on the Japanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.9x is higher than the industry's current PS ratio of 3.8x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 0.80% | |
| Healthcare | 1.10% | |
| Biotech | 2.38% | |
| Biotech | 2.38% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4587 PeptiDream | JP¥2.02k | 24.7% +JP¥51.8b | 10.9% | PE86.3x | |
| 4974 Takara Bio | JP¥1.02k | 1.4% +JP¥1.7b | -40.8% | PE78.3x | |
| 4599 StemRIM | JP¥466.00 | 5.2% +JP¥1.4b | -62.8% | PE160.1x | |
| 2929 Pharma Foods International | JP¥843.00 | 2.1% +JP¥477.2m | -49.4% | PE5x | |
| 4891 TMS | JP¥246.00 | 4.2% +JP¥403.0m | -12.8% | PB2.9x |
